$TDOC

Vandervoort Adam C sold $48K of TDOC

Vandervoort Adam C (CHIEF LEGAL OFFICER, SECRETARY) sold 7,573 shares of Teladoc Health, Inc. (TDOC) at $6.30 on 2026-09-02.

Original reporting
SEC EDGAR · Vandervoort Adam C
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
high confidence
Mentioned
$TDOC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The insider sale is modest and unlikely to affect TDOC's price, but it adds to the flow of insider activity data.

02

Market read

A routine insider sale with limited market impact; useful for tracking insider activity but not a trading catalyst.

03

What to watch

Potential upcoming regulatory or product developments not disclosed in this filing.

Relevance 3/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions; traders monitor them for potential signals.

Company-level read

Ticker impact

$TDOCNeutralHigh confidence
Context

Chief Legal Officer sold 7,573 shares for $47.7K, reducing his stake to 117,616 shares.

Expected impact

Potential slight downward pressure, but unlikely to move the stock materially.

Evidence & confidence

The sale amount is small relative to market cap and insider holdings, and no broader catalyst is indicated.

Market effects

No significant effect on the telehealth sector.

U.S. market only; negligible regional impact.

Limited global relevance.

Counterpoint

The sale could be a signal of insider concern, but the amount is too small to warrant a bearish stance.

Key entities

  • Teladoc Health, Inc.

    Provider of telehealth services, ticker TDOC.

  • Adam C. Vandervoort

    Chief Legal Officer and Secretary of Teladoc Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.